drugset / Trial / NCT05107752

Stellate Ganglion Block to Augment Trauma-focused Therapy Among Veterans With PTSD

NCT05107752

RandomizedSequentialSingle-blindTreatment

Summary

Our long-term goal is to improve clinical outcomes among patients receiving psychological treatment for posttraumatic stress disorder (PTSD). The primary objective of this project is to examine if stellate ganglion block (SGB) improves outcomes among military personnel and veterans receiving cognitive processing therapy (CPT), an empirically-supported psychological treatment for PTSD. To accomplish this objective, we will enroll adult military personnel and veterans with a current diagnosis of PTSD and/or subthreshold PTSD, provide CPT sessions over two weeks, administer SGB during or after CPT, and repeatedly assess key outcomes during follow-up.

Timeline

Start
2022-01-03
Primary completion
2025-03-31
Completion
2025-03-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Ropivacaine Other / unclassified 0.5 % Other